Affordable Access

deepdyve-link
Publisher Website

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.

Authors
  • Bafadhel, Mona1
  • Clark, Tristan W2
  • Reid, Carlene3
  • Medina, Marie-Jo4
  • Batham, Sally5
  • Barer, Michael R4
  • Nicholson, Karl G5
  • Brightling, Christopher E6
  • 1 Institute for Lung Health, University of Leicester, Leicester, England; Department of Infection, Immunity, and Inflammation, University of Leicester, Leicester, England.
  • 2 Department of Infectious Disease, University Hospitals of Leicester NHS Trust, Leicester, England.
  • 3 Institute for Lung Health, University of Leicester, Leicester, England.
  • 4 Department of Infection, Immunity, and Inflammation, University of Leicester, Leicester, England.
  • 5 Department of Infection, Immunity, and Inflammation, University of Leicester, Leicester, England; Department of Infectious Disease, University Hospitals of Leicester NHS Trust, Leicester, England.
  • 6 Institute for Lung Health, University of Leicester, Leicester, England; Department of Infection, Immunity, and Inflammation, University of Leicester, Leicester, England. Electronic address: [email protected]
Type
Published Article
Journal
CHEST Journal
Publisher
Elsevier
Publication Date
June 2011
Volume
139
Issue
6
Pages
1410–1418
Identifiers
DOI: 10.1378/chest.10-1747
PMID: 21030489
Source
Medline
License
Unknown

Abstract

Procalcitonin and CRP levels can both independently distinguish pneumonia from exacerbations of asthma. CRP levels could be used to guide antibiotic therapy and reduce antibiotic overuse in hospitalized patients with acute respiratory illness.

Report this publication

Statistics

Seen <100 times